Overview

Effectiveness, Tolerability and Safety of Rasagiline in Early Parkinson's Disease Patients Not Treated With Levodopa

Status:
Completed
Trial end date:
2000-07-01
Target enrollment:
Participant gender:
Summary
Study to look at the effectiveness, tolerability and safety of two doses of Study Medication in Early Parkinson's Disease (PD) Patients who have not been treated with Levodopa.
Phase:
Phase 3
Details
Lead Sponsor:
Teva Neuroscience, Inc.
Treatments:
Levodopa
Rasagiline